Advertisement

Topics

BIOMEDICA GRUPPE Company Profile

00:58 EST 13th December 2018 | BioPortfolio

BIOMEDICA GRUPPE Is a privately owned group of Central European companies, founded in 1978, with head-quarters in Vienna (Austria).
Starting as a single distributing company, only it grew to a
group of companies incorporating research and development,
as well as manufacturing departments.
Its main activities are the distribution of advanced and specialised
Medical Devices in the fields of cardiology, nephrology, orthopaedics,
intensive care and laboratory diagnostics for human and veterinary
applications. Through subsidiaries and associated companies the group
is represented in all countries of Central Europe.
The local offices are organised under a central management, finance and
marketing, combining the efficiency of a larger multi national
organisation with the next-door presence and customer contact in the
local language.
Biomedica Medizinprodukte GmbH & Co KG is organised in several divisions
in order to meet the special requirements of our customers in the best way.

Location

A-1210 Wien, Divischgasse 4
Austria

Contact

Phone: 43 1 291 07 56
Fax: 43 1 290 14 29
Email: sales.biomedica@bmgrp.at


News Articles [69 Associated News Articles listed on BioPortfolio]

Oxford BioMedica Notes the Longer-Term Analyses from Pivotal Kymriah Trials, Which Showed Durable Responses Are Maintained in Patients with Advanced Blood Cancers

Oxford BioMedica plc ("Oxford BioMedica" or "the Group") (LSE:OXB), a leading gene and cell therapy group, today notes an announcement by Novartis on the longer-term analyses of both the ELIANA an...

SIGNA übernimmt Möbelkette kika/Leiner

Die SIGNA-Gruppe hat die Verträge für die Übernahme von kika/Leiner unterzeichnet. Die Verträge zwischen SIGNA und der Steinhoff-Gruppe wurden am 21. Juni 2018 nach intensiven Verhandlungen R...

Axovant buys rights for Oxford BioMedica’s Parkinson’s candidate

Biopharmaceutical firm Axovant Sciences has agreed exclusive worldwide rights for the development and commercialisation of gene therapy company Oxford BioMedica’s...Read More... The post Axovant buy...

DGAP-News: Zur Rose-Gruppe gibt Ergebnis der Bezugsrechtsemission bekannt (deutsch)

Zur Rose-Gruppe gibt Ergebnis der Bezugsrechtsemission bekannt EQS Group-News: Zur Rose Group AG / Schlagwort(e): Kapitalerhöhung Zur Rose-Gruppe gibt Ergebnis der Bezugsrechtsemission bekannt 28.1.....

Oxford BioMedica: Vector Value: An Interview with Nick Woolf, SVP Corporate Strategy

Fintan Walton talks to Nick Woolf, Senior Vice President, Corporate Strategy, Oxford BioMedica, about the company’s ongoing success as it moves toward its ultimate goal of becoming a fully integrate...

Boehringer, Oxford BioMedica join on CF gene therapy project

Securing Oxford BioMedica's participation is indicative of the manufacturing hurdles present in gene therapy, particularly involving lentiviral vectors. 

DGAP-News: Zur Rose-Gruppe beantragt Kapitalerhöhung; Einladung zu einer ausserordentlichen Generalversammlung (deutsch)

Zur Rose-Gruppe beantragt Kapitalerhöhung; Einladung zu einer ausserordentlichen Generalversammlung EQS Group-News: Zur Rose Group AG / Schlagwort(e): Generalversammlung Zur Rose-Gruppe beantragt K.....

Axovant, Oxford BioMedica sign $842.5m Parkinson’s disease deal

Axovant Sciences has signed an exclusive worldwide licensing agreement with Oxford BioMedica to develop and commercialise, OXB-10, to treat Parkinson’s disease.

Drugs and Medications [0 Results]

None

Clinical Trials [0 Results]

None

Companies [19 Associated Companies listed on BioPortfolio]

BIOMEDICA GRUPPE

BIOMEDICA GRUPPE Is a privately owned group of Central European companies, founded in 1978, with head-quarters in Vienna (Austria). Starting as a single distributing company, only it grew to a group o...

Oxford BioMedica

Oxford BioMedica advanced gene therapy techniques.

Boston Biomedica Incorporated

Boston Biomedica, Inc. is an infectious diseases management company providing products and services for the detection and treatment of infectious diseases (ID) such as AIDS, Lyme Disease, and Viral He...

Oxford BioMedica plc

Oxford BioMedica (LSE:OXB) is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the...

Acolyte Biomedica Ltd

Acolyte Biomedica Ltd provides rapid diagnostic systems for clinical microbiology. Acolyte's BacLite® platform allows microbial detection in hours instead of days, improving laboratory workflow, redu...

More Information about "BIOMEDICA GRUPPE" on BioPortfolio

We have published hundreds of BIOMEDICA GRUPPE news stories on BioPortfolio along with dozens of BIOMEDICA GRUPPE Clinical Trials and PubMed Articles about BIOMEDICA GRUPPE for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BIOMEDICA GRUPPE Companies in our database. You can also find out about relevant BIOMEDICA GRUPPE Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cardiology
Cardiology is a specialty of internal medicine.  Cardiac electrophysiology : Study of the electrical properties and conduction diseases of the heart. Echocardiography : The use of ultrasound to study the mechanical function/physics of the h...


Corporate Database Quicklinks



Searches Linking to this Company Record